ORGO Forecast


Bullish Case: ORGO’s RMAT designation and Phase 3 study success for ReNu in knee osteoarthritis could expedite FDA approval, significantly boosting revenues and stock performance. [seekingalpha.com]


Bearish Case: ORGO’s repeated earnings contractions, high volatility, and modest cash reserves suggest heightened financial risk if new revenue streams falter. [seekingalpha.com]


Potential Outcomes:

1) FDA approval of ReNu (60%) – substantial revenue boost.

2) Earnings contraction continues (40%) – downward pressure on stock.

3) Expansion in Advanced Wound Care (50%) - moderate growth.

4) Failure in new studies (20%) – severe stock decline.


Trading Oracle: Trade bullish debit spreads on ORGO 01/17/2025 2.50 C/5.00 C to leverage potential FDA approval while limiting risk. Timeframe: 6-12 months, expecting a major decision by early 2025. Positive edge, high reward:risk pivot performance data from historical return surface.


July 02, 2024


Organogenesis Forecast

ORGO      Organogenesis











Correlated Assets

Assets that tend to move strongly with ORGO



VFC Forecast + Options Trading Strategies   VFC  VF (0.23)


ETRN Forecast + Options Trading Strategies   ETRN  Equitrans Midstream (0.17)


LI Forecast + Options Trading Strategies   LI  Li Auto (0.03)


XLE Forecast + Options Trading Strategies   XLE  Energy Select Sector SPDR (-0.34)



Uncorrelated Assets

Assets with little price relationship to ORGO



LI Forecast + Options Trading Strategies   LI  Li Auto (0.03)


ETRN Forecast + Options Trading Strategies   ETRN  Equitrans Midstream (0.17)


VFC Forecast + Options Trading Strategies   VFC  VF (0.23)


XLE Forecast + Options Trading Strategies   XLE  Energy Select Sector SPDR (-0.34)



Anticorrelated Assets

Assets that tend to move strongly against ORGO



VFC Forecast + Options Trading Strategies   VFC  VF (0.23)


ETRN Forecast + Options Trading Strategies   ETRN  Equitrans Midstream (0.17)


LI Forecast + Options Trading Strategies   LI  Li Auto (0.03)


XLE Forecast + Options Trading Strategies   XLE  Energy Select Sector SPDR (-0.34)





Become a more profitable investor with AI optimized trading strategies






×

Chat with ORGO


 Ask any question about ORGO!